Skip to main content

Table 9 Comparison between both groups according to ICU stay and 28-day mortality

From: Evaluation of the safety and efficacy of beta blockers in septic patients: a randomized control trial

 

Group A: control (n = 30)

Group B: esmolol (n = 30)

t test/χ2

P value

ICU stay (days)

16.2 ± 3.2

13.2 ± 3.31

− 3.569

< 0.001

28-day mortality (no)

21/30

14/30

− 4.282

0.0385

  1. Data presented as mean ± SD
  2. P value > 0.05 NS; *P value < 0.05 S; **P value < 0.001 HS
  3. There was a significant reduction in ICU stay and 28-day mortality of group B compared to group A (P value 0.001 and 0.0385, respectively) as shown in Table 9, Figs. 7 and 8